Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

Despite generally high cure rates in patients with metastatic germ cell cancer, patients with progressive disease on first-line cisplatin-based chemotherapy or with relapsed disease following high-dose salvage therapy exhibit a very poor prognosis. Irinotecan has shown antitumour activity in human t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kollmannsberger, C, Rick, O, Klaproth, H, Kubin, T, Sayer, H G, Hentrich, M, Welslau, M, Mayer, F, Kuczyk, M, Spott, C, Kanz, L, Bokemeyer, C
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2002
Soggetti:
Clinical
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364262/
https://ncbi.nlm.nih.gov/pubmed/12232755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.66000524
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi